Senseera Health
A Single Blood Test for Broad Monitoring of Human Health.
Company Overview
Snapshot
Founded in August 2020 by Ronen Sadeh, Nir Friedman, Jenia Gutin, and Israa Sharkia, Senseera Health operates with 11–50 employees. The company has secured funding across three rounds, attracting three investors, with Lightspeed Venture Partners participating in a Seed round in January 2025.
Business overview
Senseera Health is at the forefront of Health Tech & Life Sciences, developing a new generation of liquid biopsy blood tests. The company's core technology leverages molecular biology, next-generation sequencing, and advanced computational analysis to extract epigenetic information from circulating chromatin fragments in the blood. This cfChIP-seq technology provides unparalleled insights into disease processes within internal organs and the immune system. Senseera Health primarily focuses on developing accurate, sensitive, and affordable blood tests for early cancer detection and monitoring, and collaborates with pharmaceutical companies to enhance clinical trial monitoring, patient selection, and drug efficacy evaluation. The company operates within the Test Diagnostics & Screening sector, serving the healthcare and laboratory markets.
Strategic signal
In January 2025, Senseera Health successfully raised a Seed round, indicating continued investor confidence in its liquid biopsy platform. This funding suggests a positive trajectory for the company's efforts to transform disease diagnosis and treatment, particularly in the realm of early cancer detection and monitoring, and signals ongoing development and potential market expansion for its innovative blood test technology.
Company Intelligence Q&A
- What is Senseera Health's primary focus?
- Senseera Health focuses on developing a new generation of liquid biopsy blood tests that provide comprehensive information about disease processes in internal organs and the immune system from a single blood sample. Its initial product line is centered on early detection and monitoring of cancer.
- When was Senseera Health founded and by whom?
- Senseera Health was founded in August 2020 by Ronen Sadeh, Nir Friedman, Jenia Gutin, and Israa Sharkia.
- What significant funding did Senseera Health receive recently?
- In January 2025, Senseera Health raised a Seed round with participation from.
- What technology does Senseera Health utilize?
- Senseera Health employs molecular biology, next-generation sequencing, and advanced computational analysis to extract rich epigenetic information from chromatin fragments circulating in the blood, using its cfChIP-seq technology.
- Has Senseera Health engaged in any strategic collaborations?
- In November 2022, Senseera Health was part of Assuta's 'RISE with US' program, which connects startups with international markets.